• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Janus Global Life Sciences T (JAGLX)

    53.82 Up 0.46(0.86%) Dec 19
    Prev Close:53.36
    YTD Return*:32.32%
    Net Assets*:3.10B
    Yield*:N/A

    * As of 30-Nov-14

    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    • No Headlines available for JAGLX at this time.

    Top Holdings

    Symbol% AssetsYTD Return %
    GILD3.3636.07
    VRX.TO2.6824.69
    CELG2.5736.36
    MNK2.5675.60
    JNJ2.5221.49

    Fund Basics

    Morningstar Overall Rating:
    Total Assets:3.1B
    Category:Health
    Annual Report Expense Ratio (net):0.92%

    Performance & Risk

    YTD Return:32.32%
    5y Avg Return:25.16%
    Rank in Category (ytd):7
    % Rank in Category (ytd):5.56%
    Beta (3y):0.70
    Morningstar Risk Rating:3

    Fund Summary

    The investment seeks long-term growth of capital. The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets in securities of companies that the portfolio manager believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback